טוען...
Critical analysis of the potential of targeting GPC3 in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths worldwide. The treatment options for patients with advanced HCC are limited, and novel treatment strategies are required urgently. Glypican-3 (GPC3), a member of the glypican family of heparan sulfate proteoglycans, is overex...
שמור ב:
| הוצא לאור ב: | J Hepatocell Carcinoma |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove Medical Press
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4918265/ https://ncbi.nlm.nih.gov/pubmed/27508174 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JHC.S48517 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|